Cargando…
In severe liver disease, citrate can be used safely: the question remains—by which mechanism
Autores principales: | Honore, Patrick M., Mugisha, Aurore, David, Cristina, Attou, Rachid, Redant, Sebastien, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038605/ https://www.ncbi.nlm.nih.gov/pubmed/32093726 http://dx.doi.org/10.1186/s13054-020-2801-2 |
Ejemplares similares
-
Biomarkers to delineate bacteremia from candidemia remain a challenging issue
por: Honore, Patrick M., et al.
Publicado: (2020) -
Inducible metabolic pathway for citrate metabolism in case of major liver dysfunction: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2019) -
N-terminal pro-brain natriuretic peptide levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments: some confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020) -
Thrombolytic therapy during resuscitation for pulmonary embolism-related out-of-hospital cardiac arrest: perhaps not the ideal solution for everyone
por: Honore, Patrick M., et al.
Publicado: (2020) -
Endostatin shows a useful value for predicting failure to recover from acute kidney injury: some confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)